224 related articles for article (PubMed ID: 32283193)
1. Dendrimer- and polymeric nanoparticle-aptamer bioconjugates as nonviral delivery systems: a new approach in medicine.
Mignani S; Shi X; Ceña V; Majoral JP
Drug Discov Today; 2020 Jun; 25(6):1065-1073. PubMed ID: 32283193
[TBL] [Abstract][Full Text] [Related]
2. Double targeting and aptamer-assisted controlled release delivery of epirubicin to cancer cells by aptamers-based dendrimer in vitro and in vivo.
Taghdisi SM; Danesh NM; Ramezani M; Lavaee P; Jalalian SH; Robati RY; Abnous K
Eur J Pharm Biopharm; 2016 May; 102():152-8. PubMed ID: 26987703
[TBL] [Abstract][Full Text] [Related]
3. A controllable aptamer-based self-assembled DNA dendrimer for high affinity targeting, bioimaging and drug delivery.
Zhang H; Ma Y; Xie Y; An Y; Huang Y; Zhu Z; Yang CJ
Sci Rep; 2015 May; 5():10099. PubMed ID: 25959874
[TBL] [Abstract][Full Text] [Related]
4. Smart ligand: aptamer-mediated targeted delivery of chemotherapeutic drugs and siRNA for cancer therapy.
Li X; Zhao Q; Qiu L
J Control Release; 2013 Oct; 171(2):152-62. PubMed ID: 23777885
[TBL] [Abstract][Full Text] [Related]
5. Applications of Cancer Cell-Specific Aptamers in Targeted Delivery of Anticancer Therapeutic Agents.
Kim M; Kim DM; Kim KS; Jung W; Kim DE
Molecules; 2018 Apr; 23(4):. PubMed ID: 29617327
[TBL] [Abstract][Full Text] [Related]
6. Understanding the Pharmaceutical Aspects of Dendrimers for the Delivery of Anticancer Drugs.
Dubey SK; Salunkhe S; Agrawal M; Kali M; Singhvi G; Tiwari S; Saraf S; Saraf S; Alexander A
Curr Drug Targets; 2020; 21(6):528-540. PubMed ID: 31670619
[TBL] [Abstract][Full Text] [Related]
7. Targeted cancer drug delivery with aptamer-functionalized polymeric nanoparticles.
Zununi Vahed S; Fathi N; Samiei M; Maleki Dizaj S; Sharifi S
J Drug Target; 2019 Mar; 27(3):292-299. PubMed ID: 29929413
[TBL] [Abstract][Full Text] [Related]
8. Nanoparticle-aptamer bioconjugates for cancer targeting.
Farokhzad OC; Karp JM; Langer R
Expert Opin Drug Deliv; 2006 May; 3(3):311-24. PubMed ID: 16640493
[TBL] [Abstract][Full Text] [Related]
9. Aptamer-dendrimer bioconjugate: a nanotool for therapeutics, diagnosis, and imaging.
Pednekar PP; Jadhav KR; Kadam VJ
Expert Opin Drug Deliv; 2012 Oct; 9(10):1273-88. PubMed ID: 22897588
[TBL] [Abstract][Full Text] [Related]
10. A novel MUC1 aptamer-modified PLGA-epirubicin-PβAE-antimir-21 nanocomplex platform for targeted co-delivery of anticancer agents in vitro and in vivo.
Bahreyni A; Alibolandi M; Ramezani M; Sarafan Sadeghi A; Abnous K; Taghdisi SM
Colloids Surf B Biointerfaces; 2019 Mar; 175():231-238. PubMed ID: 30537619
[TBL] [Abstract][Full Text] [Related]
11. Tumor extracellular acidity activated "off-on" release of bortezomib from a biocompatible dendrimer.
Wang M; Wang Y; Hu K; Shao N; Cheng Y
Biomater Sci; 2015 Mar; 3(3):480-9. PubMed ID: 26222291
[TBL] [Abstract][Full Text] [Related]
12. Enhanced targeting of 3D pancreatic cancer spheroids by aptamer-conjugated polymeric micelles with deep tumor penetration.
Tian L; Pei R; Zhong L; Ji Y; Zhou D; Zhou S
Eur J Pharmacol; 2021 Mar; 894():173814. PubMed ID: 33352182
[TBL] [Abstract][Full Text] [Related]
13. Smart AS1411-aptamer conjugated pegylated PAMAM dendrimer for the superior delivery of camptothecin to colon adenocarcinoma in vitro and in vivo.
Alibolandi M; Taghdisi SM; Ramezani P; Hosseini Shamili F; Farzad SA; Abnous K; Ramezani M
Int J Pharm; 2017 Mar; 519(1-2):352-364. PubMed ID: 28126548
[TBL] [Abstract][Full Text] [Related]
14. Dendrimers: emerging polymers for drug-delivery systems.
Nanjwade BK; Bechra HM; Derkar GK; Manvi FV; Nanjwade VK
Eur J Pharm Sci; 2009 Oct; 38(3):185-96. PubMed ID: 19646528
[TBL] [Abstract][Full Text] [Related]
15. Engineering polymeric aptamers for selective cytotoxicity.
Yang L; Meng L; Zhang X; Chen Y; Zhu G; Liu H; Xiong X; Sefah K; Tan W
J Am Chem Soc; 2011 Aug; 133(34):13380-6. PubMed ID: 21702469
[TBL] [Abstract][Full Text] [Related]
16. Aptamer-guided nanomedicines for anticancer drug delivery.
Alshaer W; Hillaireau H; Fattal E
Adv Drug Deliv Rev; 2018 Sep; 134():122-137. PubMed ID: 30267743
[TBL] [Abstract][Full Text] [Related]
17. Combination Chemotherapy of Lung Cancer - Co-Delivery of Docetaxel Prodrug and Cisplatin Using Aptamer-Decorated Lipid-Polymer Hybrid Nanoparticles.
Wu R; Zhang Z; Wang B; Chen G; Zhang Y; Deng H; Tang Z; Mao J; Wang L
Drug Des Devel Ther; 2020; 14():2249-2261. PubMed ID: 32606595
[TBL] [Abstract][Full Text] [Related]
18. The development and testing of aptamers for cancer.
Barbas AS; White RR
Curr Opin Investig Drugs; 2009 Jun; 10(6):572-8. PubMed ID: 19513946
[TBL] [Abstract][Full Text] [Related]
19. Targeted chemoimmunotherapy using drug-loaded aptamer-dendrimer bioconjugates.
Lee IH; An S; Yu MK; Kwon HK; Im SH; Jon S
J Control Release; 2011 Nov; 155(3):435-41. PubMed ID: 21641946
[TBL] [Abstract][Full Text] [Related]
20. Aptamer applications for targeted cancer therapy.
Barbas AS; Mi J; Clary BM; White RR
Future Oncol; 2010 Jul; 6(7):1117-26. PubMed ID: 20624124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
